model make data available researcher sustainable way data sharing becomes part clinical research enterprise future mission YODA Project increase access clinical research data promote use generate new knowledge Yale University Open Data Access YODA Projects mission advocate responsible sharing clinical research data open science research transparency Project committed supporting research focused improving health patient informing science public health YODA Project improve feedback Please share comment ideas YODA Project seek mutually beneficial partnership Data Partners promoting independence responsible conduct research good stewardship data generation knowledge best interest society participate Data Partner must transfer full jurisdiction data access YODA Project YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries right search truth implies also duty one must conceal part one ha recognized true Albert Einstein Mission Yale University Open Data Access YODA Projects mission advocate responsible sharing clinical research data open science research transparency Project committed supporting research focused improving health patient informing science public health YODA Project improve feedback Please share comment ideas Model YODA Project seek mutually beneficial partnership Data Partners promoting independence responsible conduct research good stewardship data generation knowledge best interest society participate Data Partner must transfer full jurisdiction data access YODA Project Request Data ready request data date  trial identified available YODA Project Data Partners continue identify add more  Publications Featured Articles Articles making use data shared YODA Project Scroll featured article  publication  research projects Hopkins AM Modi ND Abuhelwa AY Kichenadasse G Kuderer NM Lyman GH Wiese MD McKinnon RA Rockhold FW Mann A Rowland A Sorich MJ Heterogeneity Utility Pharmaceutical Company Sharing IndividualParticipant Data Packages JAMA Oncol  Dec  doi jamaoncol PMID  PMCID PMC Almansour SA Alqudah MAY Abuhelwa Z AlShamsi HO Semreen MH Bustanji Y Soare NC McKinnon RA Sorich MJ Hopkins AM Abuhelwa AY Association proton pump inhibitor use survival adverse effect outcome patient multiple myeloma pooled analysis three clinical trials Sci Rep  Jan  doi s PMID  PMCID PMC Chen R Tie Y Huang Y Zhang X Zeng Z Chen M Li L Zhang S Rapidly achieving clinical remission ulcerative colitis indicates better endoscopic histological outcomes United European Gastroenterol J  Dec  doi ueg Epub ahead print PMID  Chekroud AM Hawrilenko M Loho H Bondar J Gueorguieva R Hasan A Kambeitz J Corlett PR Koutsouleris N Krumholz HM Krystal JH Paulus M Illusory generalizability clinical prediction models Science  Jan  doi scienceadg Epub  Jan  PMID  Harton J Segal B Mamtani R Mitra N Hubbard RA Combining realworld randomized control trial data using dataadaptive weighting via ontrial score Statistics Biopharmaceutical Research  doi Fukuokaya W Mori K Yanagisawa T Akazawa K Shimomura T Kimura T Association concomitant proton pump inhibitor use survival patient metastatic prostate cancer receiving abiraterone acetate posthoc analysis pooled data three randomized controlled trials Prostate Cancer Prostatic Dis  Jul  doi sx Epub ahead print PMID  Ruzich E Ritchie J Ginchereau Sowell F et al powerful partnership researcher patient working together develop patientfacing summary clinical trial outcome data Journal American Medical Informatics Association  JAMIA  Junocad DOI jamiaocad PMID  Samara MT Levine SZ Leucht S Linkage Young Mania Rating Scale Clinical Global Impression Scale Enhance Utility Clinical Practice Research Trials Pharmacopsychiatry  Jan doi a Epub  Jul  PMID  Nikolin S Rodgers A Schwaab A Bahji A Zarate C Jr Vazquez G Loo C Ketamine treatment major depression systematic review metaanalysis EClinicalMedicine  Aug  doi jeclinm PMID  PMCID PMC Chen R Li L Tie Y Chen M Zhang S Trajectory fecal lactoferrin predicting prognosis ulcerative colitis Precis Clin Med  Sep pbad doi pcmedipbad PMID  PMCID PMC website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries right search truth implies also duty one must conceal part one ha recognized true Albert Einstein Mission Yale University Open Data Access YODA Projects mission advocate responsible sharing clinical research data open science research transparency Project committed supporting research focused improving health patient informing science public health YODA Project improve feedback Please share comment ideas Model YODA Project seek mutually beneficial partnership Data Partners promoting independence responsible conduct research good stewardship data generation knowledge best interest society participate Data Partner must transfer full jurisdiction data access YODA Project Request Data ready request data date  trial identified available YODA Project Data Partners continue identify add more  Publications Featured Articles Articles making use data shared YODA Project Scroll featured article  publication  research projects Hopkins AM Modi ND Abuhelwa AY Kichenadasse G Kuderer NM Lyman GH Wiese MD McKinnon RA Rockhold FW Mann A Rowland A Sorich MJ Heterogeneity Utility Pharmaceutical Company Sharing IndividualParticipant Data Packages JAMA Oncol  Dec  doi jamaoncol PMID  PMCID PMC Almansour SA Alqudah MAY Abuhelwa Z AlShamsi HO Semreen MH Bustanji Y Soare NC McKinnon RA Sorich MJ Hopkins AM Abuhelwa AY Association proton pump inhibitor use survival adverse effect outcome patient multiple myeloma pooled analysis three clinical trials Sci Rep  Jan  doi s PMID  PMCID PMC Chen R Tie Y Huang Y Zhang X Zeng Z Chen M Li L Zhang S Rapidly achieving clinical remission ulcerative colitis indicates better endoscopic histological outcomes United European Gastroenterol J  Dec  doi ueg Epub ahead print PMID  Chekroud AM Hawrilenko M Loho H Bondar J Gueorguieva R Hasan A Kambeitz J Corlett PR Koutsouleris N Krumholz HM Krystal JH Paulus M Illusory generalizability clinical prediction models Science  Jan  doi scienceadg Epub  Jan  PMID  Harton J Segal B Mamtani R Mitra N Hubbard RA Combining realworld randomized control trial data using dataadaptive weighting via ontrial score Statistics Biopharmaceutical Research  doi Fukuokaya W Mori K Yanagisawa T Akazawa K Shimomura T Kimura T Association concomitant proton pump inhibitor use survival patient metastatic prostate cancer receiving abiraterone acetate posthoc analysis pooled data three randomized controlled trials Prostate Cancer Prostatic Dis  Jul  doi sx Epub ahead print PMID  Ruzich E Ritchie J Ginchereau Sowell F et al powerful partnership researcher patient working together develop patientfacing summary clinical trial outcome data Journal American Medical Informatics Association  JAMIA  Junocad DOI jamiaocad PMID  Samara MT Levine SZ Leucht S Linkage Young Mania Rating Scale Clinical Global Impression Scale Enhance Utility Clinical Practice Research Trials Pharmacopsychiatry  Jan doi a Epub  Jul  PMID  Nikolin S Rodgers A Schwaab A Bahji A Zarate C Jr Vazquez G Loo C Ketamine treatment major depression systematic review metaanalysis EClinicalMedicine  Aug  doi jeclinm PMID  PMCID PMC Chen R Li L Tie Y Chen M Zhang S Trajectory fecal lactoferrin predicting prognosis ulcerative colitis Precis Clin Med  Sep pbad doi pcmedipbad PMID  PMCID PMC website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Welcome YODA Project Remarkable quantity data generated clinical research much never published disseminated limiting integration current knowledge treatment efficacy safety data could used replicate extend previous research findings others could combined additional data enable researcher analyze result larger number patients used address secondary research question generate new knowledge challenge facing clinical research enterprise ha develop sustainable method qualified researcher clinician access data utilize advance science Sharing clinical data already existence efficient use collective scientific resource maximizes valuable contribution volunteer participate research Yale University Open Data Access YODA Project theadvocates responsible sharing clinical research data Project committed open science data transparency support research attempting produce concrete benefit patients medical community society whole experience input public stakeholders YODA Project ha iteratively developed model make data available researcher sustainable way data sharing becomes part clinical research enterprise future mission YODA Project increase access clinical research data promote use generate new knowledge Dr Harlan Krumholz open science YODA Project Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Policies  Procedures Guide External Investigator Access Clinical Trial Data Policy Guide External Investigator Access Clinical Trial Data Yale University Open Data Access YODA Project effort group academicallybased clinical researcher promote facilitate sharing clinical trial data set policies represents refinement policy guided access data made available Medtronic Inc intended cover YODA Projects partnership Johnson  Johnson also set standard relevant future effort similar aspirations Importantly YODA Project ha final decisionmaking right regarding policy and extension granting denial data requests per contractual agreement YODA Project partners serving role YODA Projects goal enhance data availability transparency support strong scientific research aim advance scientific medical knowledge ultimate goal improving public health healthcare delivery document outline YODA Projects policy guide decisionmaking related granting access data YODA Project seek continually improve policy and accordingly may modify policy future YODA Project YODA Project effort group academicallybased clinical researcher facilitate access participantlevel clinical research data andor comprehensive report clinical research full Clinical Study Reports CSRs level detail customarily found journal publications aim promoting scientific research may advance science lead improvement individual public health healthcare delivery YODA Project guided following core principles reflect overall mission project promote open science by Promoting sharing clinical research data advance science improve public health healthcarePromoting responsible conduct researchEnsuring good stewardship clinical research dataProtecting right research participant Policy ScopeThis data release policy applies request received YODA Project access clinical trial data held third party YODA Project ha agreement serve decisionmaking role regarding granting denial requests policy address research proposal requirements data receipt data analysis dissemination results Specifically policy guide procedure used make completed clinical trial data including CSRs participantlevel data available external investigator independent scientific examination policy doe apply request research partnership type data biological pharmacological radiographic data beyond scope YODA Project policy wa informed following YODA Projects prior experience sharing Medtronics participantlevel clinical trial data recombinant human bone morphogenetic protein rhBMPRecommendations YODA Project Steering Committee independent group leader field clinical research biomedical ethic convened YODA Project provide guidanceRecommendations experts stakeholders industry partners andThe YODA Projects review literature policy body engaged clinical trial data sharing Policy StatementThe YODA Project committed facilitating external access clinical trial data made available third party Data Partners promote research informs science public health project doe support request use data nonscientific purposes pursuit litigation commercial interests YODA Project require requestors provide basic information Principal Investigator Key Personnel project Research Proposal including scientific abstract research methods Registration information used YODA Project track use data promote responsible conduct research publicly post information ha obtained access data scientific purpose YODA Project review proposal ensure proposal ha scientific merit  scientific purpose clearly described  data requested used create materially enhance generalizable scientific andor medical knowledge inform science public health  proposed research reasonably addressed using requested data Scientific review peer expert andor member YODA Project Steering Committee may solicited YODA Project unable verify scientific merit proposal YODA Project request Due Diligence Assessment Data Partner requested data currently available secure data sharing platform order determine ability make data available shared externally including estimation resource would required Requestors may similarly request Assessment data yet available prior preparing full proposal Requests include independent funding considered neither expected required YODA Project willall request registration information including Research Proposal analysis plan summary Data Partner Due Diligence Assessment scientific review peer expert YODA Project Steering Committee YODA Projects decision grant deny data access access denied public report detailing reasons provided Public posting intended promote transparency clinical research public accountability YODA Project data release process Prior receiving data access requestors asked sign Data Use Agreement DUA DUA explicitly state access data used create materially enhance generalizable scientific knowledge finding derived analysis initially publicly disseminated peerreviewed biomedical literature scientific meetings exception unexpected serious safety finding which reported Data Partner immediately evaluation reporting appropriate health regulatory authorities addition requestors must certify use enable others use data commercial purpose pursuit litigation Released data include data relevant Research Proposal available including collected participantlevel data set appropriately deidentified per current regional standard protect patient privacy annotated case report forms data set specifications protocol amendments reporting analysis plans complete CSRs Depending Data Partner data made available either via passwordprotected personalized account secure data sharing platform secure electronic data transfer system details including key definitions found our Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Development Policies  Procedures Yale University Open Data Access YODA Project requested public comment policy procedure guide process used make clinical trial data available including Clinical Study Reports participantlevel data comment available below policy procedure informed following YODA Projects prior experience sharing Medtronics participantlevel clinical trial data recombinant human bone morphogenetic protein rhBMPRecommendations YODA Project Steering Committee independent group leader field clinical research biomedical ethic convened YODA Project provide guidanceRecommendations experts stakeholders industry partners andThe YODA Projects review literature policy body engaged clinical trial data sharing public comment taken consideration incorporated discretion YODA Project YODA Project seek continually improve policy and accordingly may modify policy future information found via link below Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Due Diligence Assessment Requests data already available secure data sharing platform undergo Due Diligence Assessment Data Partner primary purpose Due Diligence Assessment Data Partner provide YODA Project assessment ability make data available shared externally reviewing Data Partners legal regulatory consideration order determine legal ethical right make data available external investigator scientific purposes However Due Diligence Assessment also include estimation resource would required make data available external requestors time effort required deidentify data compliance current regional standard protect patient privacy prepare necessary accompanying documentation providing understanding technical consideration release older clinical trial data exist easily shareable format rationale collecting information broadly inform field estimate resource required Data Partners make data available Due Diligence Assessment also include determination whether researchers either internally employed externally affiliated Data Partner engaged similar research studies rationale making determination external requestors made aware similar ongoing research effort so misunderstanding generation research ideas well foster collaborations Requests data already listed available YODA Project website undergo Due Diligence Assessment Data Partner purpose only Lastly Due Diligence Assessment ass whether proposed research reasonably addressed using requested data including whether variable needed proposed analysis included requested data whether research question addressed using summarylevel data information refer toSection  theform used Johnson  Johnson Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Data Use Agreement signed Data Use Agreement DUA required data access YODA Project DUAs specific Data Partner detail specific requirement around following Data access Data use Reporting unexpectedserious safety finding Redistribution data dissemination result such DUA specific data requested carefully reviewed prior submitting data request DUA specific YODA Project Data Partner available below Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Data Expiration data regardless Data Partner expiration date one year signing DUA renewed additional time oneyear period project ongoing complete projects investigator retain right access data additional five year express purpose verification investigator publication respond inquiry regarding publication data cannot used additional analysis additional analysis require new application data access YODA Project Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Project Leadership Principal Investigator Professor Medicine General Medicine Public Health Health Policy Professor Medicine General Medicine Epidemiology Chronic Diseases Associate Professor Medicine Cardiology Senior Lecturer Institute Applied Health Sciences University Birmingham UK Assistant Professor Epidemiology Emory University Senior Project Manager Research Associate II Postgraduate Associate Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Steering Committee Steering Committee provides guidance YODA Project specifically reference developing process making clinical trial data available external investigators well process reviewing request data Steering Committee comprised leader field clinical research biomedical ethics Ezekiel J Emanuel MD PhD General Steering Committee Chairpresent Vice Provost Global Initiatives Diane vS Levy Robert M Levy University Professor Chair Department Medical Ethics Health Policy University Pennsylvania James Jim D Neaton PhDpresent Professor Biostatistics University Minnesota School Public Health Bruce M Psaty MD PhDpresent Professor Medicine Epidemiology Health Services CoDirector Cardiovascular Health Research Unit University Washington Rita Redberg MD MScpresent Cardiologist Professor Medicine University California San Francisco UCSF Core Faculty Philip R Lee Institute Health Policy Studies Chief Editor JAMA Internal Medicine Dennis Thompson PhDpresent Alfred North Whitehead Professor Political Philosophy Emeritus Harvard University Founding Director Edmond J Safra Center Ethics Deborah Zarin MDpresent Director ClinicalTrialsgov National Library Medicine YODA Project would like acknowledge following additional individual contribution endeavor Kevin J Bozic MD MBA Clinical Advisory Committee Chair Michael B Bracken MPH PhD Project Consultant Allan Coukell BScPharm General Steering Committee Member Ralph I Horwitz MD MACP General Steering Committee Member Haiqun Lin MD PhD Project Consultant Mark Litwin MD MPH Clinical Steering Committee Member Sohail K Mirza MD MPH Clinical Steering Committee Member SharonLise Normand PhD Project Consultant Regis J OKeefe MD PhD Clinical Steering Committee Member Steven D Pearson MD MSc General Steering Committee Member Daniel K Resnick MD Clinical Steering Committee Member Marc F Swiontkowski MD Clinical Steering Committee Member  Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Roles  Responsibilities YODA Project DoesThe YODA Project effort group academicallybased clinical researcher facilitate access participantlevel clinical research data andor comprehensive report clinical research full Clinical Study Reports CSRs aim promoting scientific research may advance science lead improvement individual public health healthcare delivery YODA Project ha served trusted third party variety collaborative effort make scientific data broadly available researcher betterment patients scientific research society Ongoing project include conducting independent review request access pharmaceutical medical device company data could enable new scientific discoveries expectation open science research transparency expands YODA Project continues evolve leader responsible data access maintaining touchstone core values YODA Project DoThe YODA Project ha generated owns data made available open science projects impartial perspective enables YODA Project promote principle manner uninfluenced individual stakeholder bias work mediator facilitator activist responsible data sharing Clear role responsibility delineated YODA Project Data Partners YODA Project committed to Facilitating request access clinical trial dataConducting independent thirdparty review requestsProviding access data following approval data requestsEnsuring data shared YODA Project used generate knowledge inform science public health Data Partners committed to Making possible clinical trial data available external investigatorsHandling operationaltechnical aspect data accessPosting completed trial result ClinicalTrialsgov soon available Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Partnering YODA Project Data sharing data transparency becoming new standard pharmaceutical medical device science data sharing method continue expand YODA Project strives innovative leader set standard field YODA Project approach data sharing unique following ways YODA Project independent academic organization collaborating Data Partners removing perception influence access Data Partners given YODA Project full jurisdiction make decision regarding data access YODA Project review request associated registration material ensure required information completely submitted committed facilitating external access data scientific purpose inquiry related partnering YODA Project share clinical trial data please contact Data PartnersThe Yale University Open Data Access YODA Project currently collaborating following Data Partners facilitate access clinical trial program data Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Johnson  Johnson Available Data Johnson  Johnson currently making clinical trial data pharmaceutical medical device consumer product available Johnson  Johnson ha adopted policy foster sharing clinical trial data including recently completed well older trials trial listed available Johnson  Johnson confirms location data electronic format well agreement collaboration partner ensure trial listed shared sharing site confirmed meet criteria YODA Project Johnson  Johnson continuously add list additional trial identified meet criteria case clinical trial meet criteria disclosure study data sole discretion Data Partner question availability trial currently included trial list please Pharmaceutical Data Researchers may submit request full CSRs andor deidentified participantlevel data pharmaceutical Phase IIIV clinical trial which Janssen Pharmaceutical Companies Johnson  Johnson market authorization holder product relevant indication studied approved regulator US EU study ha completed  months OPTICS Trial Bundle OPTICS Open Translational Science Schizophrenia wa project designed provide forum true translational science based Janssen clinical trial publicly available data related observational study trial schizophrenia goal wa demonstrate value openscience approach fostering collaboration leading insight disease therapeutic safety efficacy OPTICS Statement Janssen Open Translational Science Schizophrenia OPTICS Project wa launched Janssen Research  Development LLC part Janssen Pharmaceutical Companies Johnson  Johnson group leading research organization including National Institutes Health Yale University School Medicine Rutgers University Harvard TH Chan School Public Health aim project wa create forum collaborative analysis Janssens schizophrenia clinical trial data along publicly available schizophrenia data NIH ultimate goal wa create new open science model conducting research OPTICS Project wa one part larger effort Janssen Johnson  Johnson research company share clinical trial data enhance public health advance science medicine end intellectual property generated OPTICS Project wa dedicated public free use information please visit theand the OPTICS Project ha concluded available OPTICS data available YODA Project included paliperidone clinical trialsconducted Janssen Medical Device Data Researchers may submit request full CSRs andor deidentified participantlevel data as defined FDAAA medical device trial which member company Johnson  Johnson Medical Devices Companies market authorization holder product relevant indication studied approved regulator US EU  later study wa initiated  later study ha completed  months Consumer Data Researchers may submit request full CSRs andor deidentified participantlevel data interventional clinical study human consumer product regulated medicinals device which member company Johnson  Johnson Consumer Inc market authorization holder product relevant indication studied initially authorized cleared US FDA EMA health authority anywhere world US FDA EMA authorization clearance required sought allow marketing region  going forward study ha completed  months Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Data Release Pilot Project Throughout development Policy Procedures Guide External Investigator Access Clinical Trial Data YODA Project aimed support core principles Many issue idea arose throughout development process required careful consideration YODA Project move forward YODA Project spent past month determining best handle following question situations fulfill data request requested data generated many year ago shareable data files Much clinical trial data generated prior  may available paper format readily accessibleThere request data cannot legally ethically filled instance data request privacy confidentiality research participant data cannot protected clinical trial informed consent doe allow sharing deidentified data public health research educational purpose cannot filled Additionally data request compound ha obtained ha developed collaboration external partner require agreement data sharing involved partner request approvedHow much time effort required appropriate data deidentification per current regional standard protect patient privacy well preparation necessary accompanying documentation data made available YODA Project implemented staged approach data access better understand time effort data format necessary release clinical trial data data release pilot project included Due Diligence Assessment Janssen Pharmaceuticals ass following ability make data available shared externally including providing understanding technical consideration release older clinical trial data exist easily shareable formatThe informed consent documentation clinical trial interest ensure right privacy research participant upheldThe time effort required appropriate data deidentification per current regional standard protect patient privacy well preparation necessary accompanying documentation result pilot project helped inform improve YODA Project data release process Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Medtronic Overview YODA Project seek address problem unpublished selectively published clinical trial research Medtronic wa first company contract YODA Project allow access clinical trial data independent reanalysis tremendous step forward emerging era open science part initiative YODA Project first contracted two independent research group competitively selected review metaanalyze clinical study Medtronics rhBMP Oregon Evidencebased Practice Center Oregon Health  Science University OHSU Portland Oregon Centre Reviews Dissemination University York United Kingdom selected information outstanding research group found publication independent peerreviewed review metaanalyses comprehensive report theAnnals Internal Medicine Medtronics rhBMP clinical trial data made available investigator wished pursue scientific research either address unanswered question reproduce work conducted OHSU York data available investigator request June June  initiative wa important step toward open science whereby industry investigators regulator pursue transparent collaborative pathway clinical trial research ensuring patient physician best possible understanding medical product effectiveness safety Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Medtronic Systematic Reviews Overview Yale University contracted two independent research group November  perform rigorous systematic review evidence synthesis determine safety effectiveness rhBMP competitive open process Oregon Health  Science University OHSU University York selected OHSU University York completed independent review entire body scientific evidence regarding safety effectiveness recombinant human bone morphogenetic protein rhBMP team full access Medtronics clinical trial postmarketing safety data rhBMP OHSU University York independently developed final report based analysis rhBMP data links report available below report formally reviewed expert member YODA Project Steering Committees including orthopedic surgeons statisticians expert clinical trial design analysis well representative manufacturer rhBMP Medtronic Inc center refined report based reviewer feedback peerreview comment made manuscripts aim included following Identify relevant studies across user sponsor ie Medtronic sponsored othersDetermine question addressed studiesEvaluate quality studies Assess risk bias associated design conduct reporting clinical study including identified via systematic review provided Medtronic and present bias may affected assessment effectiveness harmsAssessment study design conduct include evaluation internal validity method used ascertain outcome policy procedure data collection well integrity case report form CRF adjudicationAssessment study reporting include selective publication selective reportingSummary finding includeWhat conclusion drawn assessing full body data gap knowledge remain taking account result evaluation quality risk biasAn assessment applicability studiesConduct metaanalyses study identified via systematic review appropriate using patientlevel data possible appropriate another approach summarizing data analysis consider followingFor effectiveness metaanalysis consider patientcentered outcome ie quality life functional status well surrogate outcome ie fusion determined radiographyFor safety metaanalysis include harm described Request Proposal Research Groups Oregon Health Science UniversityPrincipal Investigator Rongwei Rochelle Fu PhDAssociate ProfessorDepartment Public Health Preventive MedicineOregon Evidencebased Practice CenterOregon Health Science University OHSU University YorkPrincipal Investigator Professor Lesley StewartDirector Centre Reviews DisseminationUniversity YorkUniversity York Call Evidence Results independent review rhBMP published June   issue Annals Internal Medicine OHSUUniversity York Full comprehensive report written review organization OHSUUniversity York Commentaries Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Approved Requests Use Medtronic Data Date Data Request Approved Principal Investigator Institution Name Project Protocol Publications October   Amber Laurie MS Rochelle Fu PhD Oregon Health Science University Metaanalysis influence patient characteristic effectiveness harm recombinant human bone morphogenetic protein rhBMP lumbar spinal fusion  October   Alex Hodkinson MSc University Liverpool Differences reporting harm data internal sponsored report versus corresponding published trial reports Evaluating safety reporting rhBMP  Medtronic sponsored trial Data Transferred Project Pursued Certificate Data Destruction Received November   Andrew Indresano MD University WisconsinMadison Reevaluation Carcinogenicity rhBMP MetaAnalysis Individual ParticipantLevel Data Yale University Open Data Access YODA Project Data Transferred Project Pursued Certificate Data Destruction Received January   Vikas Patel MD University Colorado Metaanalysis Outcomes Complications Spinal Surgery Population Receiving Recombinant Human Bone Morphogenetic Protein vs Receiving Iliac Crest Bone Graft  Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Queen Mary University London Partnership Queen Mary University London March October  Yale University Open Data Access YODA Project enabled scientist across world gain access clinical trial data supporting graded exercise therapy guided selfhelp trial  compare efficacy safety guided graded exercise selfhelp GES added specialist medical care SMC SMC alone patient chronic fatigue syndrome results published Lancet June  partnership established independent process promoted open science goal leveraging prior research investment produce new knowledge YODA Project performed independent scientific review investigator request participantlevel data underlying GETSET trial QMUL conferred YODA Project authority make decision release clinical trial data allowed request clinical data fairly judged decided upon independent academic partnerNo request received use GETSET data Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries SIBONE Partnership SIBONE Inc May April  Yale University Open Data Access YODA Project enabled scientist across world gain access SIBONEs key clinical study iFuse Implant System minimally invasive surgical device indicated fusion certain disorder sacroiliac joint partnership established independent process promoted open science goal leveraging prior research investment produce new knowledge YODA Project performed independent scientific review investigator request SIBONEs clinical study iFuse Implant System including participantlevel data SIBONE conferred YODA Project authority make decision release clinical trial data allowed request clinical data fairly judged decided upon independent academic partner SIBONE shared data SIFI Sacroiliac Joint Fusion iFuse Implant System INSITE Investigation Sacroiliac Fusion Treatment studies request received use SIBONE data Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Publications  Presentations Publications Articles YODA Project Vazquez E Gouraud H Naudet F Gross CP Krumholz HM Ross JS Wallach JDClin Trials  Aug  doi  Ross JS Waldstreicher J Krumholz HMSTAT News  Ross JS Waldstreicher J Bamford S Berlin JA Childers K Desai NR Gamble G Gross CP Kuntz R Lehman R Lins P Morris SA Ritchie JD Krumholz HMSci Data  Wilcox MA Savitz AJ Addington AM Gray GS Guinan EC Jackson JW Lehner T Normand SL Ranu H Senthil G Spertus J Valeri L Ross JSNPJ Schizophr  Low J Ross JS Ritchie JD Gross CP Lehman R Lin H Fu R Stewart LA Krumholz HMSystematic Reviews  Krumholz HM Waldstreicher JNEJM  Ross JS Addington AM Senthil G Lehner T Wilcox MAPsychiatric Times  Krumholz HM Ross JS Gross CP Emanuel EJ Hodshon B Ritchie JD Low JB Lehman R AAnn Intern Med  Krumholz HM Ross JSJAMA  Articles Data Sharing Ross JS Waldstreicher J Krumholz HM N Engl J Med  Nov  doi NEJMp Epub ahead print PMID  RowhaniFarid A Grewal M Solar S Eghari A Zhang A Gross C Krumholz H Ross J Sci Data  httpsdoiorgs Tannenbaum S Ross JS Krumholz HM Desai NR Ritchie JD Lehman R Gamble GM Bachand J Schroter S Groves T Gross CPAnn Intern Med Epub ahead print  July  doi M Dey P Ross JS Ritchie JD Desai NR Bhavnani SP Krumholz HMJACC  Angraal S Ross JS Desai N Dhruva SS Krumholz HMJACC  Ross JS Ritchie JD Finn E Desai NR Lehman RL Krumholz HM Gross CPBMJ Open e Ross JSSystematic Reviews  Krumholz HM Bourne PE Kuntz RE Paz HL Terry SF Waldstreicher JJAMA epub ahead print Murugiah K Ritchie JD Desai NR Ross JS Krumholz HMJ Heart Assoc e Krumholz HM  BMJ h Rathi VK Strait KM Gross CP Hrynaszkiewicz I Joffe S Krumholz HM Dzara K Ross JSTrials Krumholz HM Peterson EDJAMA  Krumholz HM Gross CP Blount KL Ritchie JD Hodshon B Lehman R Ross JSCirc Cardiovasc Qual Outcomes  Ross JS Krumholz HMJAMA  Ross JS Krumholz HM Medical Writing  Rathi V Dzara K Gross CP Hrynaszkiewicz I Joffe S Krumholz HM Strait KM Ross JSBMJ e Krumholz HM  Circ Cardiovasc Qual Outcomes  Ross JS Lehman R Gross CP Circ Cardiovasc Qual Outcomes  Krumholz HM  Cardiology  Lehman R Loder EBMJd Articles Transparency Zou CX Becker JE Phillips AT Garritano JM Krumholz HM Miller JE Ross JSTrials  Phillips AT Desai NR Krumholz HM Zou CX Miller JE Ross JSTrials  Krumholz HM Kim JAnn Intern Med Epub ahead print  April  doi M Phillips AT Rathi VK Ross JSJAMA Intern Med  Chen R Desai NR Ross JS Zhang W Chau KH Wayda B Murugiah K Lu DY Mittal A Krumholz HM  BMJ i Gopal AD Desai NR Tse T Ross JSJAMA  Ross JSJAMA Intern Med Lauer MS Krumholz HM Topol EJLancet Shaw DL Ross JSAMA Journal Ethics  Krumholz HM  Circ Cardiovasc Qual Outcomes  Smithy JW Downing NS Ross JSJAMA Intern Med  Lehman RBMJg Becker JE Krumholz HM BenJosef G Ross JSJAMA  Ross JS Mocanu M Lampropulos JF Tse T Krumholz HMJAMA Intern Med  Ross JS Gross CP Krumholz HMAm J Public Health  Ross JS Tse T Zarin DA Xu H Zhou L Krumholz HMBMJ d Ross JS Mulvey GK Hines EM Nissen SE Krumholz HMPLoS Med e Krumholz HMRegistries selection bias Circ Cardiovasc Qual Outcomes  Wallach JD Wang K Zhang AD Cheng D Grossetta Nardini HK Lin H Bracken MB Desai M Krumholz HM Ross JSBMJ  Feb l Approved research proposal through Krumholz HMCirc Cardiovasc Qual Outcomes Presentations Given Cary P Gross MD National Brain Tumor Society Research Roundtable July   Given Joseph S Ross MD MHS National Academies Challenges Way Forward Sharing Clinical Trial Data Workshop November   Given Joseph S Ross MD MHS Center Biomedical Research Transparency Summit February   Given Joseph S Ross MD MHS American Association Advancement Science Annual Meeting February   Given Joseph S Ross MD MHS Eighth International Congress Peer Review Scientific Publication September   Given Harlan M Krumholz MD SM Jeffrey M Drazen MD Harvard Medical School Health Policy Bioethics Consortium Meeting December   Given Jessica Ritchie Klein MPH PMP American Library Association Annual Meeting June   Given Joseph S Ross MD MHS Society Clinical Trials Annual Meeting May   Given Joseph S Ross MD MHS CBI Conference Clinical Data Disclosure Transparency January   Given Joseph S Ross MD MHS NPA FDA Taskforce Meeting December   Given Kevin Bozic MD American Academy Orthopaedic Surgeons AAOS Orthopaedic Research Society ORS Clinical Research Forum February   Given Harlan Krumholz MD American College Cardiology ACC Board Trustees Meeting December   Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Announcements  Media Coverage YODA Project Announcements Yale News September   Yale News February   January  YODA Project submitted January  YODA Project submitted  Yale News August   Yale News May   April  YODA Project submitted  November  YODA Project submitted  March  YODA Project submitted response  March  YODA Project submitted response Yale Daily News January   Yale News January   Yale News October   Video YaleMedicine March   Yale News January   Yale News June   Yale News December   January  YODA Project submitted January  YODA Project submitted  Yale News August   Yale News May   April  YODA Project submitted  November  YODA Project submitted  March  YODA Project submitted response  March  YODA Project submitted response Yale Daily News January   Yale News January   Yale News October   Video YaleMedicine March   Yale News January   Yale News June   Yale News December   YODA Project Media Coverage LinkedIn September   Future Privacy Forum August   The Scientist December   James J  Pharma Tech Outlook CXO Insights May  Clinical Informatics News March   Wallach JD Ross JS Krumholz HM  BioMed Central Blog Network February   European Medicines Agency October   NEJM August   OPTICS June   Wall Street Journal April   Medical Device Diagnostic Industry January   Genetic Engineering Biotechnology News January   Vox January   Wall Street Journal January   Forbes January   JJ becomes first devicemaker broadly share trial data subscription required Modern Healthcare January   New York Times January   Vox December   Time December   subscription required Wall Street Journal December   AllTrials November   Wall Street Journal November   Scientific American June   The Scientist May   The Brown Daily Herald April   Nature Medicine March   chemistryworld February   New York Times February   JJ allow access clinical research Yale opendata project subscription required Modern Healthcare January   Johnson  Johnson January   Forbes January   Forbes January   Reuters January   subscription required Wall Street Journal January   Bloomberg January   subscription required Informa January   Xconomy January   Bloomberg Businessweek June   Minneapolis Star Tribune June   New York Times June   Wall Street Journal June   Reuters June   Medscape June   Stanford Medicine June   The Daily Edition AAOS Now February   MassDevicecom November   Minneapolis Star Tribune November   TheHeartorg October   BMJ Podcast September   BMJ August   Reuters August   New York Times August   Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Relevant Literature YODA Project recommends following article interested learning data sharing field Many article aided development YODA Project policy procedures intended comprehensive list additional resource added time NIH Data Sharing Resources National Academy Medicine Greene SM Ahmed M Chua PS Grossmann C Editors   Washington DC National Academy Medicine National Academies Sciences Engineering Medicine Washington DC National Academies Press  Institute MedicineWashington DC National Academies Press  Institute MedicineWashington DC National Academies Press  Institute MedicineWashington DC National Academies Press  Data Sharing Policies Progress Peterson ED Rockhold FWJAMA Cardiol Epub ahead print  Jul  doi jamacardio Gibson CMJAMA Cardiol Epub ahead print  Jul  doi jamacardio Yancy CW Harrington RA Bonow ROJAMA Cardiol Epub ahead print  Jul  doi jamacardio Zarin DA Tse T Williams RJ Carr SNEJM   Economist October   University Bath Stewart LA Clarke M Rovers M Riley RD Simmonds M Stewart G Tierney JFJAMA Moorthy VS Karam G Vannice KS Kieny MPLOS Med Mitka MJAMA Zarin DA Tse T Sheehan JNEJM European Medicines AgencyOctober   Varnai P Rentel MC Simmonds P Sharp TA Mostert B de Jongh TStudy led Technopolis Group UK  Bonini S Eichler HG Wathion N Rasi GNEJM Steinbrook RJAMA Intern Med Doshi P Goodman SN Ioannidis JATrends Pharm Sci Pharmaceutical Research Manufacturers America PhRMA European Federation Pharmaceutical Industries Associations EFPIAJuly   Doshi P Jefferson TJAMA Intern Med Vickers AJBMJd European Medicines AgencyNovember   Approaches Data Sharing Odame E Burgess T Arbuckle L Belcin A et al Applied Clinical Trials  Brayne C et alThe Lancet Simon GE Coronado G DeBar LL et alAnnals Int Med  epub ahead print Lo B Goodman SNJAMA Int Med  Tudur Smith C Nevitt S Appelbe D et alTrials  Munafo MR Nosek BA Bishop DVM et al  Weninger S Carrillo MC Dunn B et alAlzheimers Dement  Tudur Smith C Hopkins C Sydes M Woolfall K Clarke M Murray G Williamson PApril  El Emam K Rodgers S Malin BBMJh Sydes MR Johnson AL Meredith SK Rauchenberger M South A Parmar MKBTrials Kush R Goldman MNEJM Wilhelm EE Oster E Shoulson IJAMA Ioannidis JA Greenland S Hlatky MA Khoury MJ Macleod MR Moher D Schulz KF Tibshirani RLancet Mello MM Francer JK Wilenzick M Teden P Bierer BE Barnes MNEJM  Berman F Cerf VScience Tucker MBMJf Eichler HG Abadie E Breckenridge A Leufkens H Rasi GPLOS Mede Spertus JACirc Cardiovasc Qual Outcomes Hrynaszkiewicz I Norton ML Vickers AJ Altman DGBMJc Hrynaszkiewicz I Altman DGTrials Piwowar HA Becich MJ Bilofsky H Crowley RSPLoS Mede Importance Transparency Miller JE Wilenzick M Ritcey N Ross JS Mello MMBMJ Open e Miller JE Korn D Ross JSBMJ Open e Scherer RW UgarteGil C Schmucker C Meerpohl JJJ Clin EpidemiolEpub February   Vale CL Rydzewska LHM Rovers MM Emberson JR Gueyffier F Stewart LABMJh Ebrahim S Sohani ZN Montoya L Agarwal A Thorlund K Mills EJ Ioannidis JAJAMA Manzoli L Flacco ME DAddario M Capasso L De Vito C Marzuillo C Villari P Ioannidis JABMJg Zarin DANEJM Eichler HG Ptavy F Pignatti F Rasi GNEJM Christakis DA Zimmerman FJJAMA Rodwin MA Abramson JDJAMA Gtzsche PCCirc Cardiovasc Qual Outcomes AlsheikhAli AA Qureshi W AlMallah MH Ioannidis JAPLOS Onee Gtzsche PCTrials Savage CJ Vickers AJPLoS ONEe Zarin DA Ide NC Tse T Harlan WR West JC Lindberg DBJAMA Vickers AJTrials Patient Perspective Mello MM Lieou V Goodman SNNEJM   Lomas ABMJf Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries YODA Project Steering Committee Stakeholders Conference first conference YODA Project wa held June   Yale School Law New Haven CT data sharing conference brought together Steering Committee member well expert academia government industry guide YODA Project rhBMP data dissemination process objective conference to Identify barrier challenge data sharing Discuss feature policy public sharing Medtronics research data rhBMP Discuss strategy promote data sharing effort Ideas data sharing freely exchanged concrete list key recommendation regarding data release wa outlined feedback wa incorporated policy procedure data release YODA Project Photos Conference Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries University College London YODA Project Joint Meeting Facilitating Data Access NonIndustry Funded Research Yale University Open Data Access YODA Project brought together clinical researchers research funders patient advocates stakeholder discus challenge sharing clinical trial data nonindustry funded research first half day included series presentation reviewing current policy principle data sharing industry nonindustry funded studies served prelude broader discussion need enhance data sharing effort among academicallybased investigator possible collaboration UCL YODA Project Several clinical trial identified potential testcases sharing nonindustry funded research Meeting participant working identify next step implementing pilot project sharing data nonindustry funded studies Click following view presentation given throughout day Given Joseph S Ross MD MHS YaleNew Center Outcomes Research Evaluation Given Norman Williams PhD University College London Given Trish Groves MD BMJ Given Joseph S Ross MD MHS YaleNew Center Outcomes Research Evaluation Given Catrin Tudur Smith MSc PhD University Liverpool Given Paul Burton MD University Bristol Given Professor Lesley Stewart University York Given Iain Hrynaszkiewicz Nature Publishing Group Given Jennifer OCallaghan Wellcome Trust Given Cary P Gross MD Joseph S Ross MD MHS YaleNew Center Outcomes Research Evaluation Given Emma White PhD Administrative Data Research Centre England Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Community Data Sharing Resources Initiatives sharing using data clinical trial scientific research yielding increasing data sharing resource available scientific community YODA Project encourages exploration additional data sharing resources including  Alzheimers Disease Data Initiative ADDI house datasets tool allow increased data sharing Alzheimers disease related dementias consortium clinical study data provider facilitates access patientlevel data clinical studies Participating study sponsor include Astellas Bayer Boehringer Ingelheim Daiichi Sankyo Eisai GSK Lilly Novartis Roche Sanofi Takeda UCB ViiV Healthcare curated resource make data underlying scientific publication discoverable freely reusable citable Dryad provides generalpurpose home wide diversity datatypes Database material prepared Food Drug Administration United States medical product regulator including information clinical study trial performed evaluate safety efficacy drug approved use FDA Database material submitted European Medicines Agency European Unions medical product regulator including information clinical study trial performed evaluate safety efficacy drug medical device receive marketing authorization European Medicines Agencys Committee Human Medicinal Products CHMP per Policy  publication clinical data clinical overviews summaries study reports statistical method individual patient record information available log European Medicines Agency account repository user make research output available citable shareable discoverable manner online integrated research platform investigator search access analyze data global network study center accelerate research causes prevention treatment Alzheimers neurodegenerative diseases search engine Google help researcher locate online data freely available use Database material submitted Health Canada Canadas medical product regulator including information clinical study trial performed evaluate safety efficacy drug medical device approved use Health Canada Ascientifically independent multidisciplinary coalition global infectious disease community data sharing resource anonymised patientlevel data clinical trial sponsored LEO Pharma webbased data portal aggregates harmonizes organizes sleep clinical data thousand individual studied part cohort study clinical trial provides user suite tool facilitate data exploration data visualization listing NIHsupported data repository make data accessible reuse eg BioLINCC ClinicalTrialsgov dbGaP NIDDK GenBank etc NIHresource designed help navigate NIHwide NIH Institute Centerspecific biomedical data repository data sharing policies including link webinars resource support data preparation management access data sharing resource Pfizers clinical trialsDatabase material prepared Food Drug Administration United States medical product regulator including information clinical study trial performed evaluate safety efficacy highrisk medical device approved use FDAThe PROACT Pooled Resource Openaccess ALS Clinical Trials platform house largest ALS clinical trial dataset ever created merging data existing publicly privatelyconducted ALS clinical trial generate invaluable resource accelerating discovery field ALS free digital librarylaboratory provides one place research community broadly share integrate analyze historical patientlevel data academic industry phase III cancer clinical trials partnership Association Research Libraries Center Open Science develop free open data gathering cleaning linking enhancing metadata describes research activity outputs collaboration among member Duke Clinical Research Institute academia private industry open clinical research data benefit broader research community independent general access electronic data repository search engine individual participantlevel data metadata clinical trial conducted researcher academic industry foundation nonprofit entity identified hosted shared analyzed research data repository multidisciplinary data software conference materials educational informational content Access Zenodos content open all nonmilitary purpose only aware data sharing resource listed above Let u know Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Frequently Asked Questions FAQs Data Availability seeking summarylevel data specific trial trial request Data Partner conduct analyses YODA Project facilitating external investigator access clinical trial data made available Data Partners access allows external investigator conduct independent analysis data Requests Data Partners conduct analysis generally outofscope due resource limitations considered casebycase basis depending upon circumstance rationale available data listed YODA Project website trial listed website available sharing external investigator following approval research request Data additional trial may also available sharing however trial listed website yet reviewed determine might issue would slow prevent sharing external investigators particular trial interest listed Trials page possible share requested data externally data made available upon review approval full data request appropriate deidentification process completed data cannot released reason available provided requestor Refer YODA Section  information difference CSR Summary full CSR full Clinical Study Report CSR comprehensive overview clinical trial that general number   page provides information background rationale trial complete description study sample design intervention main outcome measures well thorough provision result primary secondary efficacy endpoint safety CSR Summary brief overview that general number   page summarizes study plan results including numerical summary efficacy safety results study objective criterion inclusion methodology etc Users required pay fee accessing data YODA Project No data provided free charge proposed research already conducted one YODA Project Data Partners YODA Project notify requestors proposed research already conducted Data Partner decision whether proceed solely requestor similar Research Proposal ha already submitted YODA Project another requestor Requestors encouraged reviewto determine similar research project already way decision proceed solely requestor encouraged YODA Project given need reproducible science product interested litigation still submit request data may request clinical trial data partnering Data Partners regardless litigation status However may certain data cannot shared various reasons including reason related litigation decision need made casebycase basis YODA Project notify requestor reason data set approved sharing Informed Consents signed patient participating clinical study data requested allow sharing data external researchers Patients investigators site agree participate clinical trial critical partner advancing medical knowledge Sharing data advancement science medicine important goal permit patient participate trial help patients Data Partners committed ensuring patient privacy maintained data clinical trial shared making certain spirit informed consent signed patient honored data shared research advance public health way protect patient confidentiality may limit ability share data instance refer Section  information Upon approval data request researcher granted access participantlevel study data devoid personally identifiable information current best guideline deidentification data used supporting documentation available trial specific supporting documentation available depends trial may include following collected datasets annotated CRFs data definition specifications protocol amendments analysis datasets statistical analysis plans andor full clinical study reports individuallists supporting documentation trial Data Request Process process submitting data request YODA Project Researchers need review  identify trial interest login create new data request Additional detail specified the employee Data Partner sharing data YODA Project follow data request process No process researcher affiliated withemployed Data Partner collaborating YODA Project one partner company contracted vendors Data Partner affiliates please utilize established internal process gaining access data set research purposes affiliated Yale University follow data request process Yes interested investigator external Data Partner including based Yale University the site YODA Project must follow YODA Project data request process example Research Proposal use template Yes instruction available Investigators also reviewas examples SCOPUS ID required apply data No SCOPUS ID required However please provide SCOPUS ID one allow tracking submitted data request using established unique identifier AScopus ID unique author identifier Elseviers Scopus database abstract citation database peerreviewed biomedical literature individual ha published article indexed conference abstract automatically assigned ID  Elsevier every team member need complete Conflict Interest statement Yes Conflict Interest statement required Principal Investigator Key Personnel Key Personnel access data analyze andor report finding use data every team member need complete Data Use Agreement Training Principal Investigator Key Personnel data access need complete training Data Use Agreement Training need completed every data request No Principal Investigator Key Personnel need complete training first data request unless otherwise determined YODA Project notified data request ha received Yes notification sent email address provided account creation upon data request receipt second notification sent stating whether additional material required data request undergoing review Research Assistant project complete data request behalf PI team member besides Principal Investigator complete data request team member creates account using one third party log options Principal Investigators information entered Project Personnel email address person receive communication YODA Project entered Email field Data Request Review Process criterion used review make decision whether Research Proposal approved YODA Project evaluate Research Proposals ensure proposal ha scientific merit  scientific purpose clearly described  data requested used create materially enhance generalizable scientific andor medical knowledge inform science public health  proposed research reasonably addressed using requested data YODA Project unable verify scientific merit proposal two independent peer review solicited investigator sufficient clinical expertise broader scientific community unaffiliated Data Partner YODA Project Upon return independent external reviews YODA Project meet least one member YODA Project Steering Committee also independently reviewed materials order make final decision grant deny data access Refer theSection  information question regarding data request submittedplan submit YODA Project contact Questions regarding data request sent to submitted Research Proposal YODA Project wa approved write additional proposals need approved YODA Project well Yes individual Research Proposal need submitted YODA Project regardless whether previous proposal approved Data Use Agreement institution ha question change DUA DUA ha prepared considerable deliberation negotiation Yale University Data Partner order best facilitate access data external investigators Please note change made exceptional circumstances required Federal State law requested change need identified using Track Changes reviewed Yale University Office Sponsored Projects OSP well Data Partner Please contactwith questions use electronic signature Data Use Agreement DUA No DUA need printed signed emailed YODA Project  notification received YODA Project Research Proposal wa approved long DUA valid expiration date one year signing DUA renewed additional time oneyear period project ongoing Upon project completion investigator destroy copy data if applicable supporting documentation Investigators shall provide certification evidencing destruction within  day expiration date investigator publication accepted right use data retained verification publication respond inquiry regarding publication five  year acceptance data cannot used additional analysis additional analysis require new application data access YODA Project Data Access long take access requested data data request ha approved time required make data available dependent several factors including many request received given time number trial requested whether External Review required evaluate scientific merit proposal whether data requested electronic format ha deidentified ready sharing external investigators time required appropriately deidentify data clarifying information received requestor aim make decision regarding approval within  days and investigator ha returned signed DUA provide access data within additional  days access data method data made available depend Data Partner One possible method involve data made available approved requestors via passwordprotected personalized account secure Safe Harbor data sharing platform Data Partners preferring method access granted maximum three researcher per approved data request relevant clinical trial data supporting documentation made available via platform Data remain secure Safe Harbor platform downloadable copied However relevant associated materials clinical study report protocols downloadable secure Safe Harbor platform addition request granted solely redacted complete CSRs distributed directly without access secure Safe Harbor platform Another possible method providing data access approved requestors involves transfer data directly requestor via secure electronic data transfer system after DUA ha signed parties Depending system data may need downloaded order used Data Use received data secure data sharing platform download data personal computer No data made available secure data sharing platform able downloaded copied work data must take place within secure platform able download supporting documentation analysis participantlevel data eg case report forms protocols CSRs Yes participantlevel data remain secure platform able downloaded copied relevant associated materials clinical study report protocols downloadable secure platform supporting documentation need destroyed upon DUA expiration want use different analytical tool perform analyses addition Stata Researchers access Stata R RStudio Notepad OpenOffice needed researcher able upload additional data set secure platform Researchers may also request additional analytical package made available secure data sharing platform YODA Project work Data Partner determine whether possible YODA Project work researcher ensure project conducted within platform report possible safety concern found data analysis possible safety concern arises data analysis reported directly Data Partner immediately evaluation reporting appropriate Health Regulatory Authorities necessary Appropriate contact information provided DUAs May use data course teaching data analysis No data cannot accessed shared third party listed data request precludes providing data student part teaching education efforts YODA Project provide technical statistical support YODA Project doe provide technical statistical support analytical support YODA Project facilitate contact Data Users Data Partners consultation desired part Data User sufficient resource available part Data Partner Transparency Data Partner know identity requestors data request review process blinded YODA Project reviewer Data Partners data access granted YODA Project post requestors identity Research Proposal summary Data Partner Due Diligence Assessment scientific review external investigator YODA Project Steering Committee YODA Projects decision grant deny data access relationship YODA Project Data Partners YODA Project independent academic organization partnering Data Partners removing perception influence access YODA Project review request associated registration material ensure required information completely submitted committed facilitating external access data scientific purposes Data Partners given YODA Project full jurisdiction make decision regarding data access YODA Project post Research Proposal publicly Yes every proposal posted YODA Project website regardless approval status along Principal Investigators name summary Data Partner Due Diligence Assessment scientific review external investigator YODA Project Steering Committee YODA Projects decision grant deny data access overview ofis available list ofis made publicly available Research result andor publication also posted YODA Project website soon available Data Partner interested partnering YODA Project do inquiry related partnering YODA Project share clinical trial data please contact Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Acknowledgements YODA Project would like acknowledge many individual contribution endeavor YODA Project General Steering Committee MembersYODA Project Clinical Steering Committee MembersSystematic Review Team Oregon Health Science UniversitySystematic Review Team University YorkYODA Project  Conference ParticipantsYODA Project ConsultantsYale Office General CouncilYale Office Sponsored Projects Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Contact Us Fields marked  required YODA Project expected continue evolve based feedback user community Data Partners general public well overall experience Please help improve project sharing commentsName Required Email Required Comments RequiredCAPTCHA Side navigation Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Request Data Instructions requesting data Start reviewing  Identify data interest data interest listed site Complete online data request requirement including Names degrees SCOPUS IDs if available Key Personnel Project funding source if applicable form PI Key Personnel Research Proposal  Specify type data requested redacted full CSRs IPD Certify information provided true requested data used pursuit litigation commercial interest Submit data request Ready begin Side navigation Request Data website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Conflict Interest Please complete Conflict Interest form either site  prefer complete receive email link download pdf Please save pdf upload data request Conflict Interest tab Side navigation Request Data website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Data Use Agreement Training Please complete YODA Project Data Use Agreement training available or complete receive email link download pdf Please save pdf upload data request Conflict Interest tab Side navigation Request Data website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Data Request Review Process outline process YODA Project review process data requests component discussed greater detail below YODA Project Review request data undergo review upon receipt YODA Project review YODA Project evaluate submitted request associated registration material ensure required information ha provided Research Proposal ha scientific merit Refer theSection  information YODA Project contact requestor additional information clarification data request needed Due Diligence Assessment Requests data already available secure data sharing platform undergo Due Diligence Assessment Data Partner Refer theSection  information External Review Requests undergo External Review YODA Project unable verify scientific merit Research Proposal Refer theSection  information YODA Project contact requestor decision made regarding data access requestor required sign submit a Depending Data Partner data made available either via passwordprotected personalized account secure data sharing platform via Yale Secure File Transfer Service Refer theSection  information Timeline Review YODA Project aim provide access data approved data request quickly possible timeline data request review data access broken follows YODA Project estimate decision grant deny data access made within  day receipt complete data request time period may affected number trial requested need External Review Research Proposal andor number request received overall goal provide access data within  day YODA Projects receipt researcher signed Data Use Agreement requestor notified timeline longer anticipated Transparency Public Posting Requests YODA Project publicly post data request associated registration materials including Research Proposals summary Data Partners Due Diligence Assessment External Reviews YODA Projects decision grant deny data access access denied public report detailing reason provided Public posting intended promote transparency clinical research public accountability YODA Project data release process Side navigation Request Data website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Request CSR Summary Clinical Study Report CSR Summary document summarizes full CSR providing highlevel overview study plan results including numerical summary efficacy safety results study objectives criterion inclusion methodology etc Data Partners committed making CSR Summaries available quickly possible CSR Summaries already available theOthers may available eitheror the interested CSR Summary listed Trials page EMA Health Canada please use form page request it NameRequired First Last EmailRequired Enter Email Confirm Email NCT  preferred NCT  unknown please provide another identifier PMID  ICTRP  biomedical literature citation Notes NCT  unique identifier National Institutes Health ClinicalTrialsgov database PMID  unique identifier National Library Medicines PubMed database ICTRP  unique identifier World Health Organizations International Clinical Trials Registry Platform provide unique identifier another database please specificAdditional trialspecific informationCAPTCHA Side navigation Request Data website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Approved Data Requests YODA Project review data request ensure proposal ha scientific merit  scientific purpose clearly described  data requested used create materially enhance generalizable scientific andor medical knowledge inform science public health  proposed research reasonably addressed using requested data Click one following Data Partners view approved data requests Side navigation Request Data website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Trials Generic Name page list trial identified availablethis complete list trial available sharing trial shared Data Partners must confirm data location availability electronic format confirm data availability conforms applicable partner agreements trial listed gone process continue add trial list regular basisDont see trials looking for Abiraterone acetate View Trials Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Ablation Catheter View Trials Enrollment  Acetaminophen View Trials Enrollment  AdCOVS View Trials Enrollment  Enrollment  Enrollment  Apalutamide View Trials Enrollment  Enrollment  Enrollment  Enrollment  Bapineuzumab View Trials Enrollment  Enrollment  BedaquilineTMC View Trials Enrollment  Enrollment  Enrollment  Bermekimab View Trials Enrollment  Enrollment  Bosentan View Trials Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Canagliflozin View Trials Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Carvykti View Trials Enrollment  Daratumumab View Trials Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Darunavir View Trials NCT Enrollment  NCT Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Decitabine View Trials Enrollment  Doxorubicin hydrochloride View Trials Enrollment  Enrollment  Epoetin alfa View Trials Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Esketamine View Trials NCT Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Ethinyl estradiol View Trials Enrollment  Etravirine View Trials Enrollment  Galantamine View Trials Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment Enrollment Enrollment  Enrollment  Enrollment  Galantamine hydrobromide View Trials Enrollment  Enrollment  Golimumab View Trials Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Graded exercise therapy View Trials Enrollment  Guselkumab View Trials Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  HEALOS Leopard Cage View Trials Enrollment  Ibrutinib View Trials Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Ibuprofen View Trials Enrollment  Enrollment  Infliximab View Trials Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment Levofloxacin View Trials Enrollment  Enrollment  Macitentan View Trials Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Mebendazole View Trials Enrollment  Enrollment  Enrollment  Methylphenidate HCl View Trials Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Miglustat View Trials Enrollment  Minoxidil  Womens Foam View Trials Enrollment  Enrollment  Mouth Rinse potassium oxalate  View Trials Enrollment  Enrollment  Enrollment  Enrollment  NA View Trials Enrollment  Enrollment  Enrollment  Enrollment  Norelgestromin View Trials Enrollment  Norgestimate View Trials Enrollment  Paliperidone View Trials Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Paliperidone palmitate View Trials Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  RafivirumabForavirumab View Trials Enrollment  Enrollment  Enrollment  Rilematovir View Trials NCT Enrollment  Enrollment  Rilpivirine View Trials Enrollment  Enrollment  Risperidone View Trials Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Selexipag View Trials Enrollment  Enrollment  Enrollment  Enrollment  Simeprevir View Trials currently trial product Sirukumab View Trials Enrollment  Enrollment  Enrollment  Enrollment  Terconazole View Trials Enrollment  TEST GENERIC NAME View Trials currently trial product Topiramate View Trials Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Toreforant View Trials Enrollment  Enrollment  Trabectedin View Trials Enrollment Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Triangular Titanium Implants View Trials Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Ustekinumab View Trials Enrollment  NCT Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  Enrollment  website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Login Login via CAS Username Email Address Password Remember Connect openidconnectgenericloginbutton Side navigation website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries YODA Project Metrics graph display complete data requests received YODA Project since October  information updated quarterly last update April   detail data requests well additional metrics use following links All request date Johnson  Johnson clinical trial data such metric specific Johnson  Johnson Data Requests YearQuarter View Graphic Chart View Tabular Data difficulty reading viewing graphic chart recommended view tabular data instead YearQuarterNot ApprovedWithdrawnClosedUnder ReviewRevisionsApproved pending signed DUA data preparationData access granted analyses progress manuscript reviewPublishedConcluded project summaryIncomplete without result reportedQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQ QQ QQQ  Filter year Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q stacked group chart visualizing statistic Data Requests YearQuarter Hide Approved Hide WithdrawnClosed Hide ReviewRevisions Hide Approved pending signed DUA data preparation Hide Data access granted analyses progress manuscript review Hide Published Hide Concluded project summary Hide Incomplete without result reported Side navigation Data Requests Inquiries CSR Summaries website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Submitted Requests Use Johnson  Johnson Data Metrics last updated May    Data Requests Received  Requests Requiring Scientific Revision Prior Approval  Median Number Days YODA Project Review IQR    Requests IPD supporting documentation  Requests full CSR Data Request Decision Approved nUnder Review  Revisions Requested nRevisions Received  Closed prior Decision nNot Approved n pie chart visualizing statistic Data Request Decision Purpose Analysis horizontal bar chart visualizing statistic Purpose Analysis New Question MetaAnalysis Validation Clinical Prediction Risk Prediction Statistical Methods Clinical Trial Methods Comparison Group PilotPreliminary Research Other  Number Trials Requested Requests  trialRequests  trialsRequests  trialsRequests  trial pie chart visualizing statistic Number Trials Requested  Multiple trials product  Multiple trials Different product disease category  Multiple trials Different product different disease category Primary Investigator Affiliations horizontal bar chart visualizing statistic Primary Investigator Affiliations Academia Industry Government  Side navigation Data Requests Inquiries CSR Summaries website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Details Data Requests Use Johnson Johnson Data Request listing updated daily Requests YODA Project post proposal data access ha granted denied Approved Requests YODA Project post approved proposal data access ha granted Withdrawn Requests following data request could fulfilled due patient privacy concerns data element availability data security concerns lack research proposal clarity YODA Project post withdrawnunapproved proposal time decision made Show Requests Filters Filters list Close Reset Search Protocol Number Product Interest PI Country PI Affiliation Year Data Access NO Trials Provided Results Project Status Reset YODA Protocol Number  Products Interest REMICADE Infliximab SIMPONI Golimumab STELARA Ustekinumab No Trials Provided  Published Publications Available Biomarkers Predicting Longterm Outcomes Ulcerative Colitis Principal Investigator Rirong Chen Reports  Publications Protocol  Associated Materials YODA Protocol Number  Products Interest ERLEADA Apalutamide No Trials Provided  Submitted YODA Project Review Publication Available External Validation Prognostic Model Overall Survival Men Metastatic CastrationResistant Prostate Cancer Principal Investigator Susan Halabi Duke University Reports  Publications Protocol  Associated Materials YODA Protocol Number  Products Interest STELARA Ustekinumab No Trials Provided  Ongoing Publication Available Comparative Efficacy Ustekinumab Infliximab One Year Outcomes Among Biologicnave Induction Responders Crohns Disease Principal Investigator Neeraj Narula Reports  Publications Cited Protocol  Associated Materials YODA Protocol Number  Products Interest REMICADE Infliximab STELARA Ustekinumab SIMPONI Golimumab No Trials Provided  Published Publication Available Predictors Placebo Response Remission Ulcerative Colitis Crohns Disease Principal Investigator Neeraj Narula Reports  Publications Cited Protocol  Associated Materials YODA Protocol Number  Products Interest STELARA Ustekinumab No Trials Provided  Published Publication Availible Comparative Effectiveness Biologics Endoscopic Healing Ileum Colon Crohns Disease Principal Investigator Neeraj Narula Reports  Publications Cited Protocol  Associated Materials YODA Protocol Number  Products Interest REMICADE Infliximab No Trials Provided  Published Publication Available Comparison Rapidity Clinical Response Infliximab Tofacitinib Ulcerative Colitis Principal Investigator Neeraj Narula Hamilton Health Sciences Reports  Publications Protocol  Associated Materials YODA Protocol Number  Products Interest STELARA Ustekinumab No Trials Provided  Published Publications Available Dominant Patient Reported Outcomes Predicting Mucosal Healing Crohns Disease Principal Investigator Neeraj Narula Reports  Publications Cited Protocol  Associated Materials YODA Protocol Number  Products Interest SPRAVATO Esketamine No Trials Provided  Published Publication Available Datasharing reanalysis main study assessed European Medicines Agency crosssectional study EPARs Principal Investigator Florian Naudet University Rennes  Reports  Publications Protocol  Associated Materials YODA Protocol Number  Products Interest STELARA Ustekinumab REMICADE Infliximab No Trials Provided  Published Publication Available Modified Multiplier SESCD MMSESCD Predicting Endoscopic Remission Crohns Disease Principal Investigator Neeraj Narula Reports  Publications Cited Protocol  Associated Materials YODA Protocol Number  Products Interest DARZALEX Daratumumab No Trials Provided  Published Publication Available Outcomes Early versus Late Response Daratumumab Patients RefractoryRelapsed Newly Diagnosed Multiple Myeloma Principal Investigator Jiasheng Wang MetroHealth Medical Center Reports  Publications Cited Protocol  Associated Materials website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Clinical Trial Inquiries CSR Summary Requests Metrics last updated May    Inquiries Received Trials Listed Site  Unique Trials Requested Answered Inquiries  Median Number Days Response Inquiry IQR   Inquiries Answered Date  Inquiries where trials made available Led Full Data Request Total Unique Trials Requested Across Answered Inquiries Trials Made AvailableTrials Cannot Made Available pie chart visualizing statistic Total Unique Trials Requested Across Answered Inquiries Trials Unavailable horizontal bar chart visualizing statistic Trials Unavailable Trial completed   mo ago ongoing Regulatory approval yet received Phase  investigator invited submit proposal  Data Partner alliance member ha agreed share Data cannot converted electronic format Materials available English Trial scope ie observational etc Data subject partner agreement researcher advised contact partner  Response Trial Inquiries View Graphic Chart View Tabular Data difficulty reading viewing graphic chart recommended view tabular data instead YearQuarterTrials Made Available Response InquiryQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQ Filter year Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q stacked group chart visualizing statistic Response Trial Inquiries Hide Trials Made Available Response Inquiry CSR Summaries Requested Provided View Graphic Chart View Tabular Data difficulty reading viewing graphic chart recommended view tabular data instead YearQuarterCSR Summaries AvailableCSR Summaries AvailableQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQ Filter year Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q stacked group chart visualizing statistic CSR Summaries Requested Provided Hide CSR Summaries Available Hide CSR Summaries Available Side navigation Data Requests Inquiries CSR Summaries website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Trials Determined Unavailable trial listed page determined unavailable YODA Project periodically reevaluates trial unavailable time inquiry following reasons Trial ongoing wa completed  month ago Regulatory approval yet received reevaluation identifies trial made available original requestors contacted list available request also found page Unavailable trial Statistics unavailable trials NCT Generic Product Name Number Inquiries Received Reason Trial Available NCT NA  Trial phase  NCT NA  Trial phase  NCT NA  Trial phase  NCT NA  Trial ongoingcompleted  month ago NCT NA  Trial ongoingcompleted  month ago NCT NA  Trial ongoingcompleted  month ago NCT Abiraterone Acetate  Trial scope ie observational etc NCT Acetaminophen  Trial ongoingcompleted  month ago NCT AdZEBOV  Regulatory approval yet received NCT AdCOVS  Trial ongoingcompleted  month ago NCT AdCOVS  Trial ongoingcompleted  month ago NCT AdCOVS  Trial ongoingcompleted  month ago NCT AdCOVS  Trial ongoingcompleted  month ago NCT AdMosHIV  Trial ongoingcompleted  month ago NCT AdRSVpreF  Trial phase  NCT Adenovirus Serotype   Trial ongoingcompleted  month ago NCT Adenovirus Serotype   Trial ongoingcompleted  month ago NCT Amivantamab  Trial ongoingcompleted  month ago NCT Amivantamab  Trial ongoingcompleted  month ago NCT Aticaprant  Regulatory approval yet received NCT Bapineuzumab  Data cannot converted electronic format NCT Bapineuzumab  Data cannot converted electronic format NCT Bedaquiline  Trial ongoingcompleted  month ago NCT Bermekimab  Trial ongoingcompleted  month ago NCT CASTSYST  Trial ongoingcompleted  month ago NCT CNTO  Trial phase  JNSJPN Concerta  Trial material available English NCT Daratumumab  Trial ongoingcompleted  month ago NCT Daratumumab  Trial ongoingcompleted  month ago NCT Daratumumab  Trial ongoingcompleted  month ago NCT DARZALEX  Trial ongoingcompleted  month ago NCT DARZALEX  Trial ongoingcompleted  month ago NCT DARZALEX  Trial ongoingcompleted  month ago NCT DARZALEX  Trial ongoingcompleted  month ago NCT DARZALEX  Trial ongoingcompleted  month ago NCT DARZALEX  Trial ongoingcompleted  month ago NCT DARZALEX  Trial ongoingcompleted  month ago NCT DARZALEX  Trial ongoingcompleted  month ago NCT DARZALEX  Trial ongoingcompleted  month ago NCT DARZALEX  Trial ongoingcompleted  month ago NCT DARZALEX  Trial ongoingcompleted  month ago NCT DARZALEX  Trial ongoingcompleted  month ago NCT DARZALEX  Trial ongoingcompleted  month ago NCT DARZALEX  Trial ongoingcompleted  month ago NCT DARZALEX  Trial ongoingcompleted  month ago NCT ECHELON FLEX GST  Trial scope ie observational etc NCT EDURANT  Trial ongoingcompleted  month ago NCT ELMIRON  Data Partner alliance member ha agreed share NCT ELMIRON  Data Partner alliance member ha agreed share NCT Erdafitinib  Trial ongoingcompleted  month ago NCT Erdafitinib  Trial ongoingcompleted  month ago NCT Erdafitinib  Trial ongoingcompleted  month ago NCT Erdafitinib  Trial phase  NCT ERLEADA  Trial ongoingcompleted  month ago NCT ERLEADA  Regulatory approval yet received NCT ERLEADA  Trial ongoingcompleted  month ago NCT Esketamine  Trial phase  NCT Esketamine  Regulatory approval yet received NCT Esketamine  Trial phase  NCT Esketamine  Regulatory approval yet received NCT Esketamine  Regulatory approval yet received NCT Esketamine  Regulatory approval yet received NCT Esketamine  Regulatory approval yet received NCT Esketamine  Regulatory approval yet received NCT Esketamine  Regulatory approval yet received NCT Esketamine  Trial phase  NCT Esketamine  Trial phase  NCT Esketamine  Regulatory approval yet received NCT Esketamine  Trial ongoingcompleted  month ago NCT Esketamine  Trial phase  NCT Esketamine  Trial ongoingcompleted  month ago NCT Esketamine  Trial ongoingcompleted  month ago NCT ExPECV  Trial ongoingcompleted  month ago NCT FAAH inhibitor  Trial phase  NCT Fentanyl  Trial material available English NCT Fentanyl  Trial material available English NCT FGFR kinase inhibitor  Trial ongoingcompleted  month ago NCT Fulranumab  Trial ongoingcompleted  month ago NCT Golimumab  Trial ongoingcompleted  month ago NCT Guselkumab  Trial phase  NCT Guselkumab  Trial phase  NCT Guselkumab  Trial phase  NCT Guselkumab  Trial phase  NCT Guselkumab  Regulatory approval yet received NCT Guselkumab  Trial ongoingcompleted  month ago NCT Guselkumab  Trial ongoingcompleted  month ago NCT IMBRUVICA  Data Partner alliance member ha agreed share NCT IMBRUVICA  Regulatory approval yet received NCT IMBRUVICA  Data Partner alliance member ha agreed share NCT IMBRUVICA  Data Partner alliance member ha agreed share NCT IMBRUVICA  Regulatory approval yet received NCT IMBRUVICA  Regulatory approval yet received NCT IMBRUVICA  Data Partner alliance member ha agreed share NCT IMBRUVICA  Trial ongoingcompleted  month ago NCT IMBRUVICA  Data Partner alliance member ha agreed share NCT IMBRUVICA  Regulatory approval yet received NCT IMBRUVICA  Regulatory approval yet received NCT IMBRUVICA  Regulatory approval yet received NCT IMBRUVICA  Regulatory approval yet received NCT IMBRUVICA  Trial ongoingcompleted  month ago NCT Imetelstat  Regulatory approval yet received NCT Imetelstat  Trial ongoingcompleted  month ago NCT Imetelstat  Trial ongoingcompleted  month ago NCT Imetelstat  Trial ongoingcompleted  month ago NCT Intraocular lens  Trial ongoingcompleted  month ago NCT INVEGA  Trial phase  NCT INVEGA  Trial phase  NCT INVEGA  Trial phase  NCT INVEGA  Trial ongoingcompleted  month ago NA sponsor ID RJPN INVEGA SUSTENNA  Trial material available English NCT INVEGA SUSTENNA  Trial ongoingcompleted  month ago NCT INVOKANA  Trial ongoingcompleted  month ago NCT INVOKANA  Trial ongoingcompleted  month ago NCT JNJ  Trial ongoingcompleted  month ago NCT JNJ  Trial ongoingcompleted  month ago NCT JNJ  Trial ongoingcompleted  month ago NCT JNJ  Trial ongoingcompleted  month ago NCT Ciltacabtagene autoleucel  Trial ongoingcompleted  month ago NCT JNJ  Trial ongoingcompleted  month ago NCT JNJ  Trial ongoingcompleted  month ago NCT JNJ  Trial ongoingcompleted  month ago NCT Lumicitabine  Regulatory approval yet received NCT Niraparib  Trial ongoingcompleted  month ago NCT PALIPERIDONE  Trial material available English NCT PALIPERIDONE  Trial material available English NCT Ponesimod  Regulatory approval yet received NCT PREZISTA  Trial ongoingcompleted  month ago NCT PREZISTA  Trial phase  NA sponsor ID TMCC PREZISTA  Trial phase  NA sponsor ID TMCC PREZISTA  Trial phase  NA sponsor ID TMCC PREZISTA  Trial phase  NA sponsor ID TMCC PREZISTA  Trial phase  NA sponsor ID TMCIFD PREZISTA  Trial phase  NCT RAZADYNE  Trial material available English NAsponsor ID GALJPN RAZADYNE  Trial material available English NA sponsor ID GALPED CR RAZADYNE  Trial scope ie observational etc NA sponsor ID RISBEL RISPERDAL  Regulatory approval yet received NA sponsor ID RISINT RISPERDAL  Data cannot converted electronic format NCT sponsor IDRISUSA RISPERDAL  Data cannot converted electronic format NCT sponsor IDRISJPNS RISPERDAL  Data cannot converted electronic format NA sponsor ID RISINT RISPERDAL  Regulatory approval yet received NA sponsor ID RISNED RISPERDAL  Regulatory approval yet received NCT RISPERDAL CONSTA  Trial phase  NCT RISPERDAL CONSTA  Trial phase  NCT Rybrevant  Trial ongoingcompleted  month ago NCT Seltorexant  Trial ongoingcompleted  month ago NCT Seltorexant  Trial ongoingcompleted  month ago NCT senofilcon  Trial ongoingcompleted  month ago NCT SIMPONI  Data Partner alliance member ha agreed share NCT SIMPONI  Data Partner alliance member ha agreed share NCT STELARA  Trial phase  NCT STELARA  Trial ongoingcompleted  month ago NCT STAR S IR Excimer laser System  Trial ongoingcompleted  month ago NCT TALVEY  Trial ongoingcompleted  month ago NCT TAR  Trial ongoingcompleted  month ago NCT TECLISTAMAB  Trial phase  NCT TECLISTAMAB  Trial ongoingcompleted  month ago NCT TECNIS Odyssey IOL  Trial ongoingcompleted  month ago NCT THERMOCOOL SMARTTOUCH RF ablation treatment  Trial ongoingcompleted  month ago TOPAMAX  Data cannot converted electronic format TOPAMAX  Data cannot converted electronic format TOPAMAX  Data cannot converted electronic format TOPAMAX  Data cannot converted electronic format TOPAMAX  Data cannot converted electronic format NCT TOPAMAX  Trial material available English NCT Tramadol HCl  Data cannot converted electronic format NCT TREMFYA  Trial ongoingcompleted  month ago NCT TREMFYA  Trial ongoingcompleted  month ago NCT TREMFYA  Regulatory approval yet received NCT TREMFYA  Trial ongoingcompleted  month ago NCT TREMFYA  Trial ongoingcompleted  month ago NCT TREMFYA  Trial phase  NCT TREMFYA  Trial ongoingcompleted  month ago NCT Transbronchial Microwave Ablation  Trial ongoingcompleted  month ago NA sponsor ID TRAMPEDS ULTRAM ULTRAM ER  Trial phase  NA sponsor ID TRAMPEDS ULTRAM ULTRAM ER  Trial phase  NA sponsor ID TRAMPEDS ULTRAM ULTRAM ER  Trial phase  NCT UPTRAVI  Trial phase  NCT Ustekinumab  Trial ongoingcompleted  month ago NCT VELCADE  Data subject partner agreement researcher advised contact Data Partner NCT VELCADE  Data subject partner agreement researcher advised contact Data Partner NCT VELCADE  Data subject partner agreement researcher advised contact Data Partner NCT VELCADE  Data subject partner agreement researcher advised contact Data Partner NCT VELCADE  Data subject partner agreement researcher advised contact Data Partner PMID  VELCADE  Data subject partner agreement researcher advised contact Data Partner NCT XARELTO  Data Partner alliance member ha agreed share NCT XARELTO  Data Partner alliance member ha agreed share regulatory approval yet received NCT XARELTO  Data Partner alliance member ha agreed share NCT XARELTO  Data Partner alliance member ha agreed share NCT XARELTO  Data Partner alliance member ha agreed share NCT XARELTO  Data Partner alliance member ha agreed share NCT XARELTO  Data Partner alliance member ha agreed share NCT XARELTO  Data Partner alliance member ha agreed share NCT XARELTO  Data Partner alliance member ha agreed share NCT XARELTO  Data Partner alliance member ha agreed share NA Xylometazoline  Trial scope ie observational etc NCT ZYTIGA  Trial phase  NCT ZYTIGA  Trial phase  NCT ZYTIGA  Trial ongoingcompleted  month ago Total  Total  Reevaluated trial available request NCT Generic Product Name Number Inquiries Received Reason Trial wa Originally Available NCT DARZALEX  Trial ongoingcompleted  month ago NCT DARZALEX  Trial ongoingcompleted  month ago NCT DARZALEX  Regulatory approval yet received NCT DARZALEX  Trial ongoingcompleted  month ago NCT IMBRUVICA  Regulatory approval yet received NCT INVOKANA  Regulatory approval yet received NCT INVOKANA  Regulatory approval yet received NCT SIMPONI  Trial ongoingcompleted  month ago NCT STELARA  Regulatory approval yet received NCT STELARA  Regulatory approval yet received NCT STELARA  Trial ongoingcompleted  month ago regulatory approval yet received NCT STELARA  Regulatory approval yet received NCT STELARA  Regulatory approval yet received NCT STELARA  Trial ongoingcompleted  month ago NCT YONDELIS  Trial ongoingcompleted  month ago NCT ZYTIGA  Trial ongoingcompleted  month ago NCT ZYTIGA  Trial ongoingcompleted  month ago NCT ZYTIGA  Trial ongoingcompleted  month ago Total  Total  Last update January   Note Inquiries trial sponsored one YODA Projects current partnering Data Partners included either lists Side navigation Data Requests Inquiries CSR Summaries website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Login Login via CAS Username Email Address Password Remember Connect openidconnectgenericloginbutton Side navigation website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Approved Data Requests YODA Project review data request ensure proposal ha scientific merit  scientific purpose clearly described  data requested used create materially enhance generalizable scientific andor medical knowledge inform science public health  proposed research reasonably addressed using requested data Click one following Data Partners view approved data requests Side navigation Request Data website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Featured Articles Hopkins AM Modi ND Abuhelwa AY Kichenadasse G Kuderer NM Lyman GH Wiese MD McKinnon RA Rockhold FW Mann A Rowland A Sorich MJ Heterogeneity Utility Pharmaceutical Company Sharing IndividualParticipant Data Packages JAMA Oncol  Dec  doi jamaoncol PMID  PMCID PMC Almansour SA Alqudah MAY Abuhelwa Z AlShamsi HO Semreen MH Bustanji Y Soare NC McKinnon RA Sorich MJ Hopkins AM Abuhelwa AY Association proton pump inhibitor use survival adverse effect outcome patient multiple myeloma pooled analysis three clinical trials Sci Rep  Jan  doi s PMID  PMCID PMC Chen R Tie Y Huang Y Zhang X Zeng Z Chen M Li L Zhang S Rapidly achieving clinical remission ulcerative colitis indicates better endoscopic histological outcomes United European Gastroenterol J  Dec  doi ueg Epub ahead print PMID  Chekroud AM Hawrilenko M Loho H Bondar J Gueorguieva R Hasan A Kambeitz J Corlett PR Koutsouleris N Krumholz HM Krystal JH Paulus M Illusory generalizability clinical prediction models Science  Jan  doi scienceadg Epub  Jan  PMID  Harton J Segal B Mamtani R Mitra N Hubbard RA Combining realworld randomized control trial data using dataadaptive weighting via ontrial score Statistics Biopharmaceutical Research  doi Fukuokaya W Mori K Yanagisawa T Akazawa K Shimomura T Kimura T Association concomitant proton pump inhibitor use survival patient metastatic prostate cancer receiving abiraterone acetate posthoc analysis pooled data three randomized controlled trials Prostate Cancer Prostatic Dis  Jul  doi sx Epub ahead print PMID  Ruzich E Ritchie J Ginchereau Sowell F et al powerful partnership researcher patient working together develop patientfacing summary clinical trial outcome data Journal American Medical Informatics Association  JAMIA  Junocad DOI jamiaocad PMID  Samara MT Levine SZ Leucht S Linkage Young Mania Rating Scale Clinical Global Impression Scale Enhance Utility Clinical Practice Research Trials Pharmacopsychiatry  Jan doi a Epub  Jul  PMID  Nikolin S Rodgers A Schwaab A Bahji A Zarate C Jr Vazquez G Loo C Ketamine treatment major depression systematic review metaanalysis EClinicalMedicine  Aug  doi jeclinm PMID  PMCID PMC Chen R Li L Tie Y Chen M Zhang S Trajectory fecal lactoferrin predicting prognosis ulcerative colitis Precis Clin Med  Sep pbad doi pcmedipbad PMID  PMCID PMC Roy S Sun Y Wallis CJD Kishan AU Morgan SC Spratt DE Malone S Saad F Prognostic Role Dynamic Changes Serological Markers Metastatic Hormone Nave Prostate Cancer Cancers Basel  Sep  doi cancers PMID  PMCID PMC Bittner N Funk CSM Schmidt A Bermpohl F Brandl EJ Algharably EEA Kreutz R Riemer TG Psychiatric Adverse Events Acetylcholinesterase Inhibitors Alzheimers Disease Parkinsons Dementia Systematic Review MetaAnalysis Drugs Aging  Nov doi sx Epub  Sep  PMID  PMCID PMC Mathai DS Nayak SM Yaden DB GarciaRomeu A Reconsidering dissociation predictor antidepressant efficacy esketamine Psychopharmacology Berl  Apr doi s Epub  Feb  PMID  Wong ECL Dulai PS Marshall JK Jairath V Reinisch W Narula N Predicting Endoscopic Improvement Ulcerative Colitis Using Ulcerative Colitis Severity Index Inflamm Bowel Dis  Apr izad doi ibdizad Epub ahead print PMID  Wong ECL Dulai PS Marshall JK Jairath V Reinisch W Narula N Delayed Ustekinumab Responders Ulcerative Colitis Greater Inflammatory Burden Similar Outcomes Early Responders Clin Gastroenterol Hepatol  Jun S doi jcgh Epub ahead print PMID  Doi Y Hamano T Yamaguchi S Sakaguchi Y Kaimori JY Isaka Y Mediators canagliflozin renoprotection vary depending patient characteristics Insights CREDENCE trial Diabetes Obes Metab  Jun  doi dom Epub ahead print PMID  Oikonomou EK Suchard MA McGuire DK Khera R PhenomappingDerived Tool Individualize Effect Canagliflozin Cardiovascular Risk Type  Diabetes Diabetes Care  Apr  doi dc PMID  PMCID PMC dAngremont E Begemann MJH van Laar T Sommer IEC Cholinesterase Inhibitors Treatment Psychotic Symptoms Alzheimer Disease Parkinson Disease Metaanalysis JAMA Neurol  Aug  doi jamaneurol PMID  PMCID PMC Chen R Tie Y Zhang X Li L Chen M Zhang S Fecal lactoferrin early predicts longterm outcome ulcerative colitis posthoc analysis UNIFI PURSUIT trials United European Gastroenterol J  Jun  doi ueg Epub ahead print PMID  Hock RS Feeney A Iovieno N et al Rapidity symptom improvement intranasal esketamine major depressive disorder systematic review metaanalysisJ Clin Psychiatry r Borisov AN Kutz A Christ ER Heim MH Ebrahimi F Canagliflozin Metabolic Associated Fatty Liver Disease Patients Diabetes Mellitus New Insights CANVAS J Clin Endocrinol Metab  May dgad doi clinemdgad Epub ahead print PMID  Wong ECL Merat S Monaco Cet alComparative Efficacy Infliximab Versus Tofacitinib Inducing Remission Biologic Naive Ulcerative Colitis Propensity Matched StudyDig Dis Sci   httpsdoiorgs Halabi S Yang Q Roy A Luo B Araujo JC Logothetis C Sternberg CN Armstrong AJ Carducci MA Chi KN de Bono JS Petrylak DP Fizazi K Higano CS Morris MJ Rathkopf DE Saad F Ryan CJ Small EJ Kelly WK External Validation Prognostic Model Overall Survival Men ChemotherapyNave Metastatic CastrationResistant Prostate Cancer J Clin Oncol  Apr JCO doi JCO Epub ahead print PMID  Burschinski A SchneiderThoma J Chiocchia V Schestag K Wang D Siafis S Bighelli I Wu H Hansen WP Priller J Davis JM Salanti G Leucht S Metabolic side effect person schizophrenia mid longterm treatment antipsychotics network metaanalysis randomized controlled trials World Psychiatry  Feb doi wps PMID  PMCID PMC Roughley MMena CHoward RReeves SBertrand JGuiding safer risperidone prescribing Alzheimers disease therapeutic drug monitoringBr J Clin Pharmacol doibcp Loiseau N Trichelair P He Met alExternal control arm analysis evaluation propensity score approaches Gcomputation doubly debiased machine learningBMC Med Res Methodol   httpsdoiorgsz VeronikiAAAshoorHMRiosP et alComparative safety efficacy cognitive enhancer Alzheimers dementia systematic review individual patient data network metaanalysisBMJ Openedoibmjopen Hopkins SC Ogirala A Zeni Cet alDepicting Risperidone Safety Profiles Clinical Trials Across Different Diagnoses Using Dopamine DBased Pharmacological Class Effect Query Defined FAERSClin Drug Investig   httpsdoiorgs S Roy Y Sun SC Morgan et al Effect Prior Local Therapy Response Firstline Androgen Receptor Axis Targeted Therapy Metastatic Castrateresistant Prostate Cancer Secondary Analysis COUAA Trial Eur Urol  httpsdoiorgj eururo Brandt L et al  Predicting psychotic relapse following randomised discontinuation paliperidone individual schizophrenia schizoaffective disorder individual participant data analysis Lancet Psychiatry   Siebert M Gaba J Renault A Laviolle B Locher C Moher D Naudet F Datasharing reanalysis main study assessed European Medicines Agencya crosssectional study European Public Assessment Reports BMC Med  May  doi s PMID  PMCID PMC Papamichael K Vande Casteele N Jeyarajah J Jairath V Osterman MT Cheifetz AS Higher Postinduction Infliximab Concentrations Associated Improved Clinical Outcomes Fistulizing Crohns Disease ACCENTII Post Hoc Analysis J Gastroenterol  May  doi ajg PMID  PMCID PMC Papamichael K Vande Casteele N Jeyarajah J Jairath V Osterman MT Cheifetz AS Higher Postinduction Infliximab Concentrations Associated Improved Clinical Outcomes Fistulizing Crohns Disease ACCENTII Post Hoc Analysis J Gastroenterol  May  doi ajg PMID  PMCID PMC Dulai PS Jairath V Narula N Wong E Kochhar GS Colombel JF Sandborn WJ Microsimulation Model Determine CostEffectiveness TreattoTarget Strategies Crohns Disease J Gastroenterol  Aug  doi ajg PMID  PMCID PMC GouraudHWallachJDBoussageonR et alVibration effect   pooled analysis individual participant data  randomised controlled trial comparing canagliflozin placebo type  diabetes mellitus multiverse analysis BMJ Medicineedoibmjmed McCutcheon RA Pillinger T Efthimiou O Maslej M Mulsant BH Young AH Cipriani A Howes OD Reappraising variability effect antipsychotic medication schizophrenia metaanalysis World Psychiatry  Jun doi wps PMID  PMCID PMC Wong ECL Dulai PS Marshall JK Jairath V Reinisch W Narula N Predictors Placebo Induction Response Remission Ulcerative Colitis Clin Gastroenterol Hepatol  Aug S doi jcgh Epub ahead print PMID  KerschbaumerARivaiZISmolenJS et alImpact preexisting background therapy placebo response randomised controlled clinical trial rheumatoid arthritisAnnals Rheumatic DiseasesPublished Online First June doiannrheumdis Zou X Huang Q Luo Y Ren Q Han X Zhou X Ji L efficacy canagliflozin diabetes subgroup stratified datadriven clustering supervised machine learning method post hoc analysis canagliflozin clinical trial data Diabetologia  Jul  doi s Epub ahead print PMID  Narula Neeraj MD MPH FRCPC Wong Emily CL BHSc Dulai Parambir S MD Marshall John K MD MSc FRCPC Jairath Vipul MD PhD Reinisch Walter MD PhDComparative Effectiveness Biologics Endoscopic Healing Ileum Colon Crohns Disease American Journal Gastroenterology April   Volume Issue ajg doi ajg Agrawal Manasi  Petralia Francesca  Tepler Adam  Durbin Laura  Reinisch Walter  Colombel JeanFrederic  Shah Shailja  GenderBased Differences Response Tumor Necrosis Factor Inhibitor Therapies Ulcerative Colitis Individual Participant Data MetaAnalyses Clinical Trials Inflammatory Bowel Diseases ibdizac Mishriky BM Cummings DM Powell JR Cardiovascular benefit GLPRA SGLTi woman type  diabetes Prim Care Diabetes  Apr S doi jpcd Epub ahead print PMID  Khan FA Stewart I Moss S Fabbri L Robinson KA Johnson SR Jenkins RG ThreeMonth FVC Change Trial Endpoint IPF Based Individual Participant Data MetaAnalysis J Respir Crit Care Med  Jan  doi rccmOC Epub ahead print PMID  Kearns B Stevenson MD Triantafyllopoulos K Manca A Comparing current emerging practice model extrapolation survival data simulation study casestudy BMC Med Res Methodol  Nov  doi s PMID  PMCID PMC Narula N Wong ECL Colombel JF Sandborn WJ Ferrante M Marshall JK Reinisch W Dulai PS Early Reduction MMSESCD Score Initiation Biologic Therapy Highly Specific OneYear Endoscopic Remission Moderate Severe Crohns Disease J Crohns Colitis  Oct jjab doi eccojccjjab Epub ahead print PMID  Narula N Pray C Wong ECL Colombel JF Marshall JK Daperno M Reinisch W Dulai PS Categorizing Endoscopic Severity Crohns Disease Using Modified Multiplier SESCD MMSESCD J Crohns Colitis  Feb jjac doi eccojccjjac Epub ahead print PMID  Mellem MS Kollada M Tiller J Lauritzen T Explainable AI enables clinical trial patient selection retrospectively improve treatment effect schizophrenia BMC Med Inform Decis Mak  May  doi s PMID  PMCID PMC CarreteroGonzlez A Lora D Manneh R Lorente D Castellano D de Velasco G Combination statinvitamin metastatic castrationresistant prostate cancer CRPC post hoc analysis two randomized clinical trials Clin Transl Oncol  Nov doi s Epub  Mar  PMID  Wang R Dasgupta A Ward MM Predicting Probability Response Tumor Necrosis Factor Inhibitors Individual Patients Ankylosing SpondylitisJAMA Netw Opene doijamanetworkopen Wang J ArroyoSuarez R Dasari S Sekaran K Tse W Early versus late response daratumumabbased triplet therapy patient multiple myeloma pooled analysis trial POLLUX CASTOR MAIA Leuk Lymphoma  Feb  doi  Epub ahead print PMID  Wong ECL Dulai PS Marshall JK Jairath V Reinisch W Narula N Resolution dominant patientreported outcome end induction predicts clinical endoscopic remission Crohns disease Aliment Pharmacol Ther  Feb  doi apt Epub ahead print PMID  Brandt L SchneiderThoma J Siafis S Efthimiou O Bermpohl F Loncar L Neumann K Hasan A Heinz A Leucht S Gutwinski S Adverse event antipsychotic discontinuation individual participant data metaanalysis Lancet Psychiatry  Mar doi S PMID  Sim R Chong CW Loganadan NK et al Comparative effectiveness cardiovascular renal safety outcome secondline antidiabetic drug use people type  diabetes systematic review network metaanalysis randomised controlled trials Diabet Med  Dec e doi dme Epub ahead print PMID  Beelen EMJ Nieboer D Arkenbosch JHC et al Risk Prediction Comparative Efficacy AntiTNF v Thiopurines Preventing Postoperative Recurrence Crohns Disease Pooled Analysis  Trials Clin Gastroenterol Hepatol  Oct S doi jcgh Epub ahead print PMID  BenHorin S Novack L Mao R et al Efficacy Biologic Drugs ShortDuration Versus LongDuration Inflammatory Bowel Disease Systematic Review IndividualPatient Data MetaAnalysis Randomized Controlled Trials Gastroenterology  Feb doi jgastro Epub  Oct  PMID  Zhu Y Centorrino F Jackson JW Fitzmaurice GM Valeri LEpidemiology  Jan doi EDE PMID  Narula N Wong ECL Marshall JK Colombel JF Dulai PS Reinisch WClin Gastroenterol Hepatol  Jul SX doi jcgh Epub ahead print PMID  Lorente D Llacer C Lozano R et alEuropean Urology  doi httpsdoiorgjeururo Schoretsanitis G Kane JM Correll CU Rubio JMSchizophrenia Bulletin sbab httpsdoiorgschbulsbab Hieronymus F Klbk P Correll CU stergaard SDnpj Schizophrenia  Hodkinson A Heneghan C Mahtani KR Kontopantelis E Panagioti MBMC Med  Aug  doi sw PMID  PMCID PMC Pan J Wang J Wei Y Zhang T Zhang S Ye D Zhu YCancer Med  Aug  doi cam Epub ahead print PMID  Narula N Aruljothy A Wong ECL Homenauth R Alshahrani AA Marshall JK Reinisch WUnited European Gastroenterol J Jun doi ueg Epub  Jun  PMID  PMCID PMC Wang L Paller C Hong H Rosman L De Felice A Brawley O Alexander GCJ Natl Cancer Inst Apr djab doi jncidjab Epub ahead print PMID  Ternov KK Nolse AB Bratt O Fode M Lindberg H Kistorp C Palapattu G Klausen TW Snksen J stergren PBProstate Cancer Prostatic Dis  Apr  doi s Epub ahead print PMID  Wang J Park C ArroyoSuarez RLeuk Lymphoma Apr  doi  Epub ahead print PMID  Narula N Wong ECL Dulai P Sengupta NK Marshall JK Colombel JFReinisch WClin Gastroenterol Hepatol  Apr  doi httpsdoiorgjcgh Epub ahead print Narula N Wong ECL Colombel JF Sandborn WJ Marshall JK Daperno M Reinisch W Dulai PGut  Mar gutjnl doi gutjnl Epub ahead print PMID  Narula N Wong ECL Dulai PS Marshall JK Colombel JF Reinisch WJ Crohns Colitis  Mar jjab doi eccojccjjab Epub ahead print PMID  Fraenkel L Wei Z Ramsey C Wiedmeyer C Michaud K Neogi T Nowell WB Venkatachalam S Broniatowski DAPLoS One  Jan e doi journalpone PMID  Mishriky BM Okunrintemi V Jain S Sewell KA Powell JR Cummings DMDiabetes Metab  May S doi jdiabet Epub ahead print PMID  Papamichael K Vande Casteele N Jeyarajah J Jairath V Osterman MT Cheifetz ASAm J GastroenterolDecember  Publish Ahead Print Marques ML Ramiro S Machado PM van der Heijde D van Gaalen FARMD Open  Dece doi rmdopen PMID  Lu TX Dapas M Lin E Peters T Sakuraba AGut  Dec gutjnl doi gutjnl Epub ahead print PMID  Rabinowitz J Young RC Yavorsky C Williams JBW Sedway J Marino P Matteo C Mahableshwarkar A Kott A Hefting N Engler J Brady C Consistency check improve measurement Young Mania Rating Scale YMRS J Affect Disord  Jan  doi jjad Epub  Oct  PMID  Wong ECL Marshall JK Reinisch W Narula NInflamm Bowel Dis  Aug  izaadoi ibdizaaOnline ahead print Hanlon P Butterly E Lewsey J Siebert S Mair FS McAllister DABMC Med  Oct  doi s PMID  PMCID PMC Narula N Wong ECL Dulai PS Marshall JK Colombel JF Reinisch WJ Crohns Colitis Sep jjaa doi eccojccjjaa Epub ahead print PMID  Ferreira RJO Welsing PMJ Jacobs JWG Gossec L Ndosi M Machado PM van der Heijde D Da Silva JAPAnn Rheum Dis Oct  doi annrheumdis Epub ahead print Rubio JM Schoretsanitis G John M Tiihonen J Taipale H Guinart D Malhotra AK Correll CU Kane JMLancet Psychiatry  doiS Narula N Wong ECL Aruljothy A Dulai PS Colombel JF Marshall JK Ferrante M Reinisch W J Gastroenterol  doiajg Faleck DM Shmidt E Huang R Katta LG Narula N Pinotti R SuarezFarinas M Colombel JFClin Gastroenterol Hepatol Epub ahead print  Jun  S doijcgh Hanlon P Hannigan L RodriguezPerez J Fischbacher C Welton NJ Dias S Mair FS Guthrie B Wild S McAllister DABMC Med Nov  doi s Cheng D Cushing KC Cai T Ananthakrishnan ANClin Gastroenterol Hepatol  May pii S doi jcgh Epub ahead print Spertus J HorvitzLennon M Normand SMed Decis Making Aug XEpub ahead print doiX Christian KE Russman KM Rajan DP Barr EA Cross RKInflamm Bowel Dis  Jul  pii izz doi ibdizz Epub ahead print SchneiderThoma JEfthimiou OBighelli IDrries CHuhn MKrause MReichelt LRder HFurukawa TA Davis JMLeucht SLancet Psychiatry  July  doiS Singh S Proudfoot JA Dulai PS Xu R Feagan BG Sandborn WJ Jairath VClin Gastroenterol Hepatol May piiS doi jcgh Epub ahead print Waljee AK Wallace BI CohenMekelburg S Liu Y Liu B Sauder K Stidham RW Zhu J Higgins PDRJAMA Netw Open Maye doi jamanetworkopen Teply BA Qiu F Antonarakis ES Carducci MA Denmeade SRProstate  Jun doi pros Mbuagbaw L Guglielmetti L Hewison C Bakare N Bastard M Caumes E FrchetJachym M Robert J Veziris N Khachatryan N Kotrikadze T Hayrapetyan A Avaliani Z Schnemann HJ Lienhardt CEmerg Infect Dis  May doi eid Waljee AK Sauder K Zhang Y Zhu J Higgins PDRClin Gastroenterol Hepatol  Mar doi jcgh Yiu ZZN Mason KJ Barker JNWN Hampton PJ McElhone K Smith CH Warren RB Griffiths CEM Lunt M Burden AD BADBIR Study GroupBr J Dermatol Epub ahead print  Mar  doi bjd Loubersac T NguileMakao M Pouliot F Fradet V Toren PEur Urol Oncol  doi j euo Martin LJ Alibhai SMH Komisarenko M Timilshina N Finelli ACan Urol Assoc J Epub ahead print  Nov  doi cuaj Kumagai F Suzuki T Fleischhacker WW YasuiFurukori N Mimura M Uchida HJ Clin Psychiatry  Dec  pii m doi JCPm Kubo K Fleischhacker WW Suzuki T YasuiFurukori N Mimura M Uchida HActa Psychiatr ScandEpub ahead print  Sep  doi acps Narula N Alshahrani AA Yuan Y Reinisch W Colombel JFClin Gastroenterol HepatolEpub ahead print  Jun  doi jcgh SchneiderThoma J Efthimiou O Huhn M Krause M Reichelt L Rder H Davis JM Salanti G Leucht SLancet Psychiatry doi S Wilcox MA Savitz AJ Addington AM Gray GS Guinan EC Jackson JW Lehner T Normand SL Ranu H Senthil G Spertus J Valeri L Ross JSNPJ Schizophr doi s Spertus J HorvitzLennon M Abing H Normand SNPJ SchizophrEpub ahead print  June  doi s Zou X Zhu Y Jackson JW Bellavia A Fitzmaurice GM Centorrino F Valeri LNPJ SchizophrEpub ahead print  June  doi s Singh S Proudfoot J Xu R Sandborn WJInflamm Bowel DisEpub ahead print  May  doi ibdizy Singh S Proudfoot J Xu R Sandborn WJAm J Gastroenterol  doi sx Singh S Proudfoot JA Dulai PS Jairath V Fumery M Xu R Feagan BG Sandborn WJAm J Gastroenterol Epub ahead print  June  doi s Mbuagbaw LAppendix inA  review available evidence use bedaquiline treatment multidrugresistant tuberculosis Geneva  reference number WHOHTMTB Wang R Dasgupta A Ward MMJ Rheumatol Epub ahead print  January  doi jrheum Gay HC Baldridge AS Huffman MDJAMA Cardiology Epub ahead print  October  doi jamacardio Corbett M Chehadah F Biswas M MoeByrne T Palmer S Soares M Walton M Harden M Ho P Woolacott N Bojke LHealth Technology Assessment  Fu R Selph S McDonagh M Peterson K Tiwari A Chou R Helfand MAnn Intern Med  Mospan GA Wargo KAJ Board Fam Med  Laurie AL Chen Y Chou R Fu RSpine E Noshchenko A Lindley EM Burger EL Cain CM Patel VVSpine  Simmonds MC Brown JV Heirs MK Higgins JP Mannion RJ Rodgers MA Stewart LAAnn Intern Med  VeronikiAAStrausSEAshoorHM et al Comparative safety effectiveness cognitive enhancer Alzheimers dementia protocol systematic review individual patient data network metaanalysis BMJ Openedoibmjopen website designed YODA Project Menu Policies  Procedures Data Partners Johnson  Johnson Medtronic Conferences Request Request Data Metrics Data Requests Inquiries CSR Summaries Site Map Table Contents Pages Article Features Clinical TrialsData Requests website designed